AstraZeneca at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

AstraZeneca brings 8 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 624. The drugmaker's posters report real-world use and safety of trastuzumab deruxtecan, ESR1 mutations and liquid biopsy uptake in HR-positive disease, and AI models that read tumor slides.

OrganizationSABCS 2026 Attendance
AstraZeneca
Cambridge, UK
Pharma
Global drugmaker whose breast cancer medicines include HER2- and TROP2-directed antibody-drug conjugates and treatments for hormone receptor-positive disease.
Booth
Exhibiting at Booth 624
Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm
Poster
Thu Dec 10
12:30–2pm
Multimodal Foundation Models Unlock Transcriptomic Subtypes from Routine H&E Slides in TNBC
Exhibit Hall
Artificial Intelligence, Computational Biology, and Systems Biology

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at AstraZeneca

Tell us what you sell and we’ll find the people at AstraZeneca most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction